Alliance Pharma (APH)
17/10/2017 - 08:45 StockMarketWire
Hardman Research has issued a report noting that Alliance Pharma's Kelo-cote brand is building international sales. Hardm...
17/10/2017 - 08:14 RNS
RNS Number: 7998T Alliance Pharma PLC 17 October 2017 Hardman Research: Kelo-cote building international sales Kelo-cote building international sales - Alliance Pharma's buy-and-build strategy to evolve into a profitable, cash generative, specialty pharma business is bearing fruit. Acquisition of the dermatology and woundcare products from Sinclair Pharma ha...
13/09/2017 - 06:52 StockMarketWire
Alliance Pharma's revenues rose by 8% to 50.3m in the six months to the end of June. EBITDA increased by 3% to 13.6m an...
13/09/2017 - 06:00 RNS
RNS Number: 5694Q Alliance Pharma PLC 13 September 2017 For immediate release 13 September 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Interim Results for the six months ended 30 June 2017 Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, is pleased to announce its interim results for the six months ended 30 June ...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment